- Home
- NVCR vs PGNY Comparison
NVCR vs PGNY Comparison
Compare NVCR & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCR | PGNY |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 2.1B |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NVCR | PGNY |
|---|---|---|
| Price | $13.62 | $27.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $28.42 | $27.44 |
| AVG Volume (30 Days) | ★ 1.9M | 1.4M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.96 |
| EPS | N/A | ★ 0.62 |
| Revenue | $642,269,000.00 | ★ $1,268,689,000.00 |
| Revenue This Year | $9.75 | $11.55 |
| Revenue Next Year | $5.62 | $9.52 |
| P/E Ratio | ★ N/A | $43.68 |
| Revenue Growth | 11.17 | ★ 11.41 |
| 52 Week Low | $10.70 | $14.12 |
| 52 Week High | $32.06 | $27.76 |
Technical Indicators
Market Signals| Indicator | NVCR | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 60.58 | 66.32 |
| Support Level | $12.30 | $25.58 |
| Resistance Level | $13.94 | $26.84 |
| Average True Range (ATR) | 0.61 | 0.80 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 86.51 | 83.29 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.